Back
Novartis AG Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Buy
62
NVS
Novartis AG
Last Price:
103.39
Seasonality Move:
1.51%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Novartis AG Price Quote
$103.39
-0.47 (-0.45%)
(Updated: November 14, 2024 at 5:55 PM ET)
Novartis AG Key Stats
Buy
62
Novartis AG (NVS)
is a Buy
Day range:
$103.38 - $104.16
52-week range:
$92.35 - $120.92
Dividend yield:
3.6%
P/E ratio:
14.78
P/S ratio:
4.31
P/B ratio:
4.84%
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
10.38%
Market cap:
$209.8B
Revenue:
$46.7B
EPS:
$8.53
How Much Does Novartis AG Make?
-
How Much Are Novartis AG's Sales Annually?
NVS Revenues are $46.7B -
How Much Profit Does Novartis AG's Make A Year?
NVS net income is $14.9B
Is Novartis AG Growing As A Company?
-
What Is Novartis AG's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.09% -
What Is Novartis AG's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.85%
Novartis AG Stock Price Performance
-
Did Novartis AG Stock Go Up Last Month?
Novartis AG share price went down by -10.64% last month -
Did NVS's Share Price Rise Over The Last Year?
NVS share price rose by 10.38% over the past 1 year
What Is Novartis AG 52-Week High & Low?
-
What Is Novartis AG’s 52-Week High Share Price?
Novartis AG has traded as high as $120.92 over the past 52 weeks -
What Is Novartis AG’s 52-Week Low Share Price?
Novartis AG has traded as low as $92.35 over the past 52 weeks
Novartis AG Price To Free Cash Flow
-
Is Novartis AG Stock Overvalued?
Novartis AG is trading at a price to free cash flow ratio of 17.20 -
Is Novartis AG Stock Undervalued?
Novartis AG EV to Free Cash Flow ratio is 18.08 -
What Is Novartis AG’s Price Earnings Growth Ratio?
NVS PEG ratio is 0.10 -
Is Novartis AG Trading At A Premium To Earnings?
Novartis AG EV to EBIT ratio is 16.53
Is It Risky To Buy Novartis AG?
-
How Much Debt Does Novartis AG Have?
Total long term debt quarterly is $30.3B -
How Much Cash Does Novartis AG Have?
Cash and short term investments quarterly total is $14B -
What Is Novartis AG’s Book Value Per Share?
Book value per share is 21.67
Is Novartis AG Cash Flow Positive?
-
What Is NVS Cash Flow From Operations?
Cash flow from operations (TTM) is $16B -
What Is Novartis AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$9.4B -
What Is Novartis AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$6.2B
Novartis AG Return On Invested Capital
-
Is Management Doing A Good Job?
NVS return on invested capital is 25.8% -
What Is Novartis AG Return On Assets?
ROA measures how assets are converting to revenues and is 17.33% -
What Is NVS Return On Equity?
ROE is a measure of profitability and is 41.89%
Novartis AG Earnings Date & Stock Price
-
What Is Novartis AG's Stock Price Today?
A single share of NVS can be purchased today for 103.86 -
What Is Novartis AG’s Stock Symbol?
Novartis AG trades on the nyse under the ticker symbol: NVS -
When Is Novartis AG’s Next Earnings Date?
The next quarterly earnings date for Novartis AG is scheduled on January 31, 2025 -
When Is NVS's next ex-dividend date?
Novartis AG's next ex-dividend date is March 7, 2024 -
How To Buy Novartis AG Stock?
You can buy Novartis AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novartis AG Competitors
-
Who Are Novartis AG's Competitors?
Below is a list of companies who compete with Novartis AG or are related in some way:
Novartis AG Dividend Yield
-
What Is NVS Dividend Yield?
Novartis AG’s dividend yield currently is 3.6% -
What Is Novartis AG’s Payout Ratio?
Novartis AG’s payout ratio is 43.31% -
When Did Novartis AG Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Novartis AG’s Dividend Per Share?
Novartis AG pays a dividend of $0.00 per share
Novartis AG Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 84.71% | 6.57% |
| Revenue: | 8.93% | 1.24% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 11 |
| Sell Recommendations: | 0 |
| Price Target: | 116.16 |
| Upside from Last Price: | 11.84% |